97 related articles for article (PubMed ID: 20072948)
41. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
Bergman J; Reznichek RC; Rajfer J
BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
[TBL] [Abstract][Full Text] [Related]
42. Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests.
Bánkfalvi A; Boecker W; Reiner A
Int J Oncol; 2004 Oct; 25(4):929-35. PubMed ID: 15375542
[TBL] [Abstract][Full Text] [Related]
43. Human epidermal growth-factor receptor 2 overexpression in gastric carcinoma in Thai patients.
Sornmayura P; Rerkamnuaychoke B; Jinawath A; Euanorasetr C
J Med Assoc Thai; 2012 Jan; 95(1):88-95. PubMed ID: 22379747
[TBL] [Abstract][Full Text] [Related]
44. Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis.
Bánkfalvi A; Giuffrè G; Ofner D; Diallo R; Poremba C; Buchwalow IB; Barresi V; Böcker W; Tuccari G
Int J Oncol; 2003 Nov; 23(5):1285-92. PubMed ID: 14532967
[TBL] [Abstract][Full Text] [Related]
45. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice.
Laudadio J; Keane TE; Reeves HM; Savage SJ; Hoda RS; Lage JM; Wolff DJ
BJU Int; 2005 Dec; 96(9):1280-5. PubMed ID: 16287445
[TBL] [Abstract][Full Text] [Related]
46. Changing frequency of equivocal HER-2/neu scores and factors predictive of negative HER 2/neu fluorescent in situ hybridisation in invasive carcinomas of the breast.
Boulos F; Farra CG; Saad Aldin EM; Masaad C; Hassoun Y; Fedda F; Doumiati H; Tawil AN; Nasser Z; Nahleh Z; Tfayli A
J Clin Pathol; 2014 Mar; 67(3):204-9. PubMed ID: 24108431
[TBL] [Abstract][Full Text] [Related]
47. The role of immunohistochemistry in the analysis of the spectrum of small round cell tumours at a tertiary care centre.
D'cruze L; Dutta R; Rao S; R A; Varadarajan S; Kuruvilla S
J Clin Diagn Res; 2013 Jul; 7(7):1377-82. PubMed ID: 23998069
[TBL] [Abstract][Full Text] [Related]
48. HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A study of two hundred cases.
Sáez A; Andreu FJ; Seguí MA; Baré ML; Fernández S; Dinarés C; Rey M
Breast; 2006 Aug; 15(4):519-27. PubMed ID: 16290155
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Molecular and Immunohistochemical Adjunct Modalities in the Diagnosis of Soft Tissue Neoplasms.
Mourtzoukou D; Fisher C; Thway K
Int J Surg Pathol; 2015 Dec; 23(8):601-8. PubMed ID: 26310271
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic utility of automated SureFISH (Dako Omnis) in the diagnosis of musculoskeletal translocation-related sarcomas.
Sugita S; Aoyama T; Ito Y; Asanuma H; Sugawara T; Segawa K; Ito Y; Kikuchi N; Tsujiwaki M; Fujita H; Ono Y; Hasegawa T
Pathol Int; 2017 Oct; 67(10):510-513. PubMed ID: 28735509
[TBL] [Abstract][Full Text] [Related]
51. Value of electron microscopy and immunohistochemistry in the diagnosis of soft tissue tumors.
Kandel R; Bedard YC; Fan QH
Ultrastruct Pathol; 1998; 22(2):141-6. PubMed ID: 9615383
[TBL] [Abstract][Full Text] [Related]
52. An update on the application of newly described immunohistochemical markers in soft tissue pathology.
Lin G; Doyle LA
Arch Pathol Lab Med; 2015 Jan; 139(1):106-21. PubMed ID: 25549147
[TBL] [Abstract][Full Text] [Related]
53. Co-expression of multiple cytokines and their receptors in primary clear cell sarcoma of the pubic bone with features of a small round cell tumor.
Nakayama S; Yokote T; Iwaki K; Hirata Y; Akioka T; Miyoshi T; Takayama A; Nishiwaki U; Masuda Y; Tsuji M; Hanafusa T
Int J Immunopathol Pharmacol; 2012; 25(3):799-804. PubMed ID: 23058034
[TBL] [Abstract][Full Text] [Related]
54. THE IMPORTANCE OF IMMUNOHISTOCHEMICAL STUDIES IN THE DIAGNOSIS OF CANCER OF UNKNOWN PRIMARY ORIGIN.
Beisenayeva A; Cialkowska-Rysz A; Zhumaliyeva V; Omarova I; Kabildina N; Sirota V
Georgian Med News; 2015 Dec; (249):73-80. PubMed ID: 26719554
[TBL] [Abstract][Full Text] [Related]
55. [Interphase fluorescence in situ hybridization in the diagnosis of clinical pathology].
Ye HT
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):130-4. PubMed ID: 21426819
[No Abstract] [Full Text] [Related]
56. [The use of immunohistochemical slides for performing FISH as a useful method of conserving tissue samples].
Tauziède-Espariat A; Mehdi L; Roux A; Zaomi M; Pucelle N; Lacombe J; Gigant P; Berthaud C; Brigot E; Massé J; Collard A; Métais A; Hasty L; Chrétien F; Varlet P; Lechapt E
Ann Pathol; 2023 Jan; 43(1):7-12. PubMed ID: 35710499
[TBL] [Abstract][Full Text] [Related]
57. Molecular classification of soft tissue sarcomas for adequate diagnosis: A study on the northeast population of Morocco.
El Koubaiti R; Mazti A; Maaroufi M; El Idrissi M; El Ibrahimi A; El Mrini A; Bouhafa T; El Fakir S; Ouldim K; Arifi S; Chbani L
Heliyon; 2022 Sep; 8(9):e10673. PubMed ID: 36164527
[TBL] [Abstract][Full Text] [Related]
58. A retrospective analysis of immunohistochemical staining in identification of poorly differentiated round cell and spindle cell tumors--results, reagents and costs.
Leong AS; Wannakrairot P
Pathology; 1992 Oct; 24(4):254-60. PubMed ID: 1283898
[TBL] [Abstract][Full Text] [Related]
59. [Clinicopathological analysis of infantile/congenital fibrosarcomas with rare histological features].
Qi GW; Zheng J; Ma YY; Lou Y; Chen L
Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):700-704. PubMed ID: 31495090
[No Abstract] [Full Text] [Related]
60. A novel technology allowing immunohistochemical staining of a tissue section with 50 different antibodies in a single experiment.
Furuya T; Ikemoto K; Kawauchi S; Oga A; Tsunoda S; Hirano T; Sasaki K
J Histochem Cytochem; 2004 Feb; 52(2):205-10. PubMed ID: 14729872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
